Stabilization of tetanus toxoid formulation containing aluminium hydroxide adjuvant against freeze-thawing

23Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Exposure to subzero temperature leads to loss of vaccine potency. This can happen due to degradation of adjuvant surface and/or inactivation of the antigen. When adsorbed on aluminium hydroxide and subjected to freeze-thawing, tetanus toxoid was desorbed from the gel matrix and the preparation was found to lose its antigenicity. Analyses showed that the gel particles were denatured after freezing. When freeze-thawing was carried out in the presence of glucose, sorbitol and arginine, the degradation of gel particles was inhibited. A higher fraction of the protein could be retained on the gel. However, the antigenicity of these preparations was quite low. In the presence of trehalose, the protein could be partially retained on aluminium hydroxide. Being a cryoprotectant, trehalose was also able to inhibit the freezing-induced denaturation of tetanus toxoid, which resulted in retention of antigenicity of the adjuvanted toxoid. © 2011 Elsevier B.V.

Cite

CITATION STYLE

APA

Solanki, V. A., Jain, N. K., & Roy, I. (2011). Stabilization of tetanus toxoid formulation containing aluminium hydroxide adjuvant against freeze-thawing. International Journal of Pharmaceutics, 414(1–2), 140–147. https://doi.org/10.1016/j.ijpharm.2011.05.022

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free